The effect of the ecstasy 'come-down' on the diagnosis of ecstasy dependence

Drug and Alcohol Dependence

Volumn 139, Issue , 2014, Pages 26-32

  McKetin, Rebecca ^a,b   Copeland, Jan ^c   Norberg, Melissa M ^b,c,d   Bruno, Raimondo ^b,e   Hides, Leanne ^f   Khawar, Laila ^b  

^a AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d MACQUARIE UNIVERSITY   (Australia)

^e UNIVERSITY OF TASMANIA   (Australia)

^f QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

3; 4 methylenedioxy N methylamphetamine; Dependence; Diagnosis; Ecstasy; Prevalence; Withdrawal

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; STREET DRUG;

ADULT; ARTICLE; AUSTRALIA; DRUG DEPENDENCE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RATING SCALE; SEVERITY OF DEPENDENCE SCALE; STRUCTURED CLINICAL INTERVIEW FOR DSM DISORDERS; WITHDRAWAL SYNDROME; ADOLESCENT; FACTORIAL ANALYSIS; INTERVIEW; MIDDLE AGED; PSYCHOLOGY; SEVERITY OF ILLNESS INDEX; SUBSTANCE WITHDRAWAL SYNDROME; SUBSTANCE-RELATED DISORDERS; TIME; YOUNG ADULT;

ADOLESCENT; ADULT; FACTOR ANALYSIS, STATISTICAL; FEMALE; HUMANS; INTERVIEWS AS TOPIC; MALE; MIDDLE AGED; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; SEVERITY OF ILLNESS INDEX; STREET DRUGS; SUBSTANCE WITHDRAWAL SYNDROME; SUBSTANCE-RELATED DISORDERS; TIME FACTORS; YOUNG ADULT;

EID: 84899924217     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2014.02.697     Document Type: Article

References (26)

1. American Psychiatric Association, 2000. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR) Retrieved from PsychiatryOnline.com.
2. American Psychiatric Association, 2013. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. American Psychiatric Association, Washington, DC [access date: 1 June 2013]. dsm.psychiatryonline.org.
3. Bruno R., Matthews A.J., Dunn M., Alati R., McIlwraith F., Hicky S., Burns L., Sindicich N. Emerging psychoactive substance use among regular ecstasy users in Australia. Drug Alcohol Depend. 2012, 124:19-25.
4. Bruno R., Matthews A.J., Topp L., Degenhardt L., Gomez R., Dunn M. Can the Severity of Dependence Scale be usefully applied to 'ecstasy'?. Neuropsychobiology 2009, 60:137-147.
5. Cottler, L. B., Leung, K. S., Abdallah, A. B., 2009. Test-re-test reliability of DSM-IV adopted criteria for 3,4-methylenedioxymethamphetamine (MDMA) abuse and dependence: a cross-national study. Addiction 104, 1679-1690.
6. Cottler L.B., Womack S.B., Compton W.M., Ben-Abdallah A. Ecstasy abuse and dependence among adolescents and young adults: applicability and reliability of DSM-IV criteria. Hum. Psychopharmacol. 16, 599-606. Davison, D., Parrott, A. C., 1997. Ecstasy (MDMA) in recreational users: self-reported psychological and physiological effects. Hum. Psychopharmacol. 2001, 12:221-226.
7. Degenhardt L., Bruno R., Topp L. Is ecstasy a drug of dependence?. Drug Alcohol Depend. 2010, 107:1-10.
8. DiClemente C.C., Schlundt D., Gemmell L. Readiness and stages of change in addiction treatment. Am. J. Addict. 2004, 13:103-119.
9. First M.B., Gibbon M., Spitzer R.L., Williams J.B.W. User's Guide for the Structured Clinical Interview for DSM-IV-TR Axis I Disorders - Research Version - (SCID-I for DSM-IV-TR) 2002, Biometrics Research, New York State Psychiatric Institute, New York.
10. Gawin F.H., Ellinwood E.H. Cocaine and other stimulants. N. Engl. J. Med. 1988, 318:1173-1182. doi:10.1056/NEJM198805053181806.
11. Haro J.M., Arbabzadeh-Bouchez S., Brugha T.S., de Girolamo G., Guyer M.E., Jin R., Lepine J.P., Mazzi F., Reneses B., Vilagut G., Sapson N.A., Kessler R.C. Concordance of the Composite International Diagnostic Interview Version 3, 0 (CIDI 3.0) with standardized clinical assessments in the WHO World Mental Health surveys. Int. J. Methods Psychiatr. Res 2006, 15:167-180.
12. Lawrinson P., Copeland J., Indig D. Development and validation of a brief instrument for routine outcome monitoring in opioid maintenance pharmacotherapy services: the brief treatment outcome measure (BTOM). Drug Alcohol Depend 2005, 80:125-133.
13. McConnaughy E.A., Prochaska J.O., Velicer W.F. Stages of change in psychotherapy: measurement and sample profiles. Psychotherapy: Theory, Research Practice 1983, 20:368-375. 10.1037/h0090198.
14. McGregor C., Srisurapanont M., Jittiwutikarn J., Laobhripatr S., Wongtan T., White J.M. The nature, time course and severity of methamphetamine withdrawal. Addiction 2005, 100:1320-1329.
15. Morefield K.M., Keane M., Felgate P., White J.M., Irvine R.J. Pill content, dose and resulting plasma concentrations of 3,4-methylendioxymethamphetamine (MDMA) in recreational 'ecstasy' users. Addiction 2011, 106:1293-1300.
16. Morgenstern J., Langenbucher J., Labouvie E. The generalisability of the dependence syndrome across substances: an examination of some properties of the proposed DSM-IV dependence criteria. Addiction 1994, 89:1105-1115.
17. Nelson C., Rehm J., Üstün T., Grant B., Chatterji S. Factor structures for DSM-IV substance disorder criteria endorsed by alcohol, cannabis, cocaine and opiate users: results from the WHO reliability and validity study. Addiction 1999, 94:843-855.
18. Nichols, D. E., 1994. Medicinal chemistry and structure-activity relationships. In: Cho, A.K., Segal, D.S. (Eds.), Amphetamine and its Analogs, Academic Press, San Diego pp. 3-41.
19. Parrott A.C. Chronic tolerance to recreational MDMA (3,4-methylenedioxymethamphetamine) or ecstasy. J. Psychopharmacol. 2005, 19:71-83.
20. Schrieber J., Stage F., King J., Nora A., Barlow E. Reporting structural equation and confirmatory factor analysis results: a review. J. Educ. Res. 2006, 99:323-337.
21. Sindicich, N., Burns, L., 2013. Australian Trends in Ecstasy and related Drug Markets 2011: Findings from the Ecstasy and Related Drugs Reporting System (EDRS). Australian Drug Trend Series No. 100. National Drug and Alcohol Research Centre, University of New South Wales, Sydney.
22. Stata Corporation, 2011. Stata/SE 11.2 for Windows. StataCorp LP, College Station, Texas.
23. Topp, L., Hall, W., Hando, J., 1997. Is There a Dependence Syndrome for Ecstasy? National Drug and Alcohol Research Centre, Sydney.
24. United Nations Office on Drugs and Crime, 2013. World Drug Report 2013. United Nations, New York.
25. Verheyden S.L., Henry J.A., Curran H.V. Acute, sub-acute and long-term subjective consequences of 'ecstasy' (MDMA) consumption in 430 regular users. Human Psychopharmacology: Clinical and Experimental 2003, 18:507-517. 10.1002/hup.529.
26. Yen C.-F., Hsu S.-Y. Symptoms of ecstasy dependence and correlation with psychopathology in Taiwanese adolescents. J. Nerv. Ment. Dis. 2007, 195:866-869.